Living with lung cancer often means spending more time in waiting rooms than in the moments that matter, but a new South ...

At the recent CURE Educated Patient® Lung Cancer Summit, held in tandem with the 2025 PER® New York Lung Cancer Symposium, Dr ...

Lung cancer remains the leading cause of cancer death, but advances in screening, surgery and personalized treatment are ...

Nuvalent said its drug for ALK+ lung cancer shrank tumors in more than a quarter of patients whose disease had returned after ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Traditionally, lung cancer is associated with older patients, specifically men who smoked. But doctors say that's beginning ...

Nuvalent has reported phase 1/2 lung cancer data, teeing the biotech up to talk to the FDA about an approval filing that could establish its neladalkib as a challenger to Pfizer’s Lorbrena.

"In the middle of all the scans I thought... I'm fit and healthy... people like me don't get lung cancer, so to say it was a ...

For Dusty Donaldson, one journey led to another. After navigating the emotional path of a lung cancer diagnosis, operation, ...

This summer, 75-year-old Antioch Township Treasurer and Mesick resident Kathy Soerries was preparing for a family vacation to ...

Each year, about 209,000 Americans are told they have lung cancer, and about 132,000 people die from the disease, according ...

When you think of lung cancer, you probably think of a disease that only afflicts lifelong smokers. This is just one of the ...